… In this meta-analysis, we included 21 studies reporting data on safety and 13 studies reporting
data on … -reported outcomes associated with the use of direct-acting oral anticoagulants …

… clinical data in morbidly obese patients. The aim of the meta-analysis was to compare
DOACs with warfarin in morbidly obese patients with atrial fibrillation (AF) and to optimize an …

… meta-analysis was to compare efficacy and safety of direct oral anticoagulants (DOACs) to
warfarin for … The purpose of the present meta-analysis was therefore to investigate the efficacy …

… The objective of present study was to compare the safety and efficacy of resuming direct-acting
oral anticoagulants (DOACs) and vitamin K antagonists (VKAs) in patients with atrial …

… who are either underweight or obese and underutilization of these agents in this patient …
meta-analysis is to investigate the clinical consequences of the use of DOACs in patients …

… a network meta-analysis to assess … meta-analysis of RCT, we found that DOACs are more
effective and similarly safe compared to warfarin irrespective of the diabetic status of the patient…

… This meta-analysis shows that DOACs have GIB safety profiles comparable to that of warfarin.
However, the risk of fatal GIB was lower with DOACs. These findings are in concordance …

… A total of 36 eligible studies were included in this systematic review and meta-analysis (the
process of study identification is described in Supplementary Fig. 1). Inter-observer …

… Results: There were 21,185 patients from seven studies included in this systematic review
and meta-analysis. Stroke and systemic embolism were lower in patients receiving DOACs […

… anticoagulant use for chronic kidney disease (CKD) patients. We compared the efficacy and
safety of direct-acting oral anticoagulants (… vitamin K antagonists (VKA) in patients with CKD …